Laboratory Medicine ›› 2019, Vol. 34 ›› Issue (1): 89-91.DOI: 10.3969/j.issn.1673-8640.2019.01.020
Previous Articles Next Articles
Received:2017-12-13
Online:2019-01-30
Published:2019-01-29
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2019.01.020
| [1] | KAMAL A H,TEFFERI A,PRUTHI R K.How to interpret and pursue an abnormal prothrombin time,activated partial thromboplastin time,and bleeding time in adults[J]. Mayo Clin Proc,2007,82(7):864-873. |
| [2] | HALE G,BRENNER M.Risks and benefits of low molecular-weight heparin and target-specific oral anticoagulant use for thromboprophylaxis in medically ill patients[J]. Am J Cardiovasc Drugs,2015,15(5):311-322. |
| [3] | GENZEN J R,TORMEY C A,Education Committee of the Academy of Clinical Laboratory Physicians and Scientists. Pathology consultation on reporting of critical values[J]. Am J Clin Pathol,2011,135(4):505-513. |
| [4] | 喻宁芳,邓穗德,潘海祥,等. 低HCT患者凝血四项的抗凝剂剂量实验观察[J]. 实用检验医师杂志,2013,5(4):257-258. |
| [5] | CHAKRAVARTY K,ONG V H,DENTON C P.Secondary vasculitis in autoimmune connective tissue diseases[J]. Curr Opin Rheumatol,2016,28(1):60-65. |
| [6] | JOG N R,JAMES J A.Biomarkers in connective tissue diseases[J]. J Allergy Clin Immunol,2017,140(6):1473-1483. |
| [7] | 叶淼,楼亚玲,王伟群,等. 低浓度纤维蛋白原对不同仪器凝血功能检测的影响[J]. 现代实用医学,2011,23(3):324-326. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
